Is ENOV or INGN more undervalued in 2026?

CirclFi compares Enovis Corporation (ENOV) and Inogen, Inc (INGN) using 13 institutional-grade valuation models. ENOV has a Quality of Company score of 5.0/10 while INGN scores 6.6/10.

Which is a better buy — ENOV or INGN?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ENOV and INGN valuations compare?

ENOV at $22.68 and INGN at $6.49 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ENOV vs INGN Valuation Comparison 2026 — Intrinsic Value Analysis

ENOV

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Enovis Corporation

Quality

5.0

out of 10

Value Trap

LOW

Price

$22.68

Last close

Models

10/13

Active

INGN

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Inogen, Inc

Quality

6.6

out of 10

Value Trap

LOW

Price

$6.49

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	ENOV Fair Value	ENOV Upside	INGN Fair Value	INGN Upside
Bayesian DCF	Intrinsic	$13.78	-39.2%	$2.83	-56.4%
Earnings Power Value	Intrinsic	$4.62	-79.7%	$9.45	+45.7%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ENOV vs INGN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ENOV vs INGN — Which Stock Is More Undervalued?

INGN scores higher with a 6.6/10 quality rating vs ENOV's 5.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Enovis Corporation (ENOV) and Inogen, Inc (INGN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ENOV currently trades at $22.68 with a QOC of 5.0/10, while INGN trades at $6.49 with a QOC of 6.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).